Richard F Newland1, Robert A Baker2, Richard J Woodman3, Mary B Barnes3, Timothy W Willcox4. 1. Quality and Outcomes, Cardiothoracic Surgical Unit, Flinders Medical Centre, Adelaide, Australia; Perfusion Service, Cardiothoracic Surgical Unit, Flinders Medical Centre, Adelaide, Australia; Department of Surgery, College of Medicine and Public Health, Flinders University, Adelaide, Australia. 2. Quality and Outcomes, Cardiothoracic Surgical Unit, Flinders Medical Centre, Adelaide, Australia; Perfusion Service, Cardiothoracic Surgical Unit, Flinders Medical Centre, Adelaide, Australia; Department of Surgery, College of Medicine and Public Health, Flinders University, Adelaide, Australia. Electronic address: rob.baker@sa.gov.au. 3. Flinders Centre for Epidemiology and Biostatistics, Flinders University, Adelaide, Australia. 4. Greenlane Perfusion, Auckland City Hospital, Auckland, New Zealand; Department of Anaesthesia, University of Auckland, Auckland, New Zealand.
Abstract
BACKGROUND: The randomized goal-directed perfusion trial confirmed retrospective findings that a goal-directed perfusion strategy to maintain oxygen delivery index (DO2i) during cardiopulmonary bypass greater than 280 mL/min/m2 reduces the incidence of acute kidney injury (AKI). We developed a predictive model for AKI using data from the Australian and New Zealand Collaborative Perfusion Registry to determine whether these findings could be validated in a real-world clinical setting and to identify an optimal DO2i threshold for predictive diagnostic accuracy. METHODS: Data in 19,410 cardiopulmonary bypass procedures were randomly divided into training (n = 9705) and validation (n = 9705) datasets. Multivariate logistic regression was used to determine the best predictive models for AKI (RIFLE [renal Risk, Injury, Failure, Loss of renal function and End-stage renal disease] classification), incremental predictive value of minimum cardiopulmonary bypass DO2i, and optimal threshold. RESULTS:Minimum DO2i was significantly associated with any AKI, AKI risk, and AKI injury or greater class in both datasets (validation dataset; any AKI odds ratio [OR], 0.993; 95% confidence interval [CI], 0.991-0.995; P < .001; AKI risk OR, 0.994; 95% CI, 0.992-0.996; P < .001, AKI injury or greater 0.993; 95% CI, 0.991-0.996; P < .001), representing on average a 7% increase in the likelihood of AKI for every 10-mL/min/m2 decrease in DO2i. Diagnostic accuracy was similar for both datasets, with an optimal DO2i threshold of 270 mL/min/m2. The odds of any AKI were increased by 52% in those below the threshold (OR, 1.52; 95% CI, 1.29-1.77; P < .001). CONCLUSIONS: This study confirms previous findings that minimum DO2i during cardiopulmonary bypass is independently associated with AKI, supporting previous findings in a broader-risk, multicenter cohort.
RCT Entities:
BACKGROUND: The randomized goal-directed perfusion trial confirmed retrospective findings that a goal-directed perfusion strategy to maintain oxygen delivery index (DO2i) during cardiopulmonary bypass greater than 280 mL/min/m2 reduces the incidence of acute kidney injury (AKI). We developed a predictive model for AKI using data from the Australian and New Zealand Collaborative Perfusion Registry to determine whether these findings could be validated in a real-world clinical setting and to identify an optimal DO2i threshold for predictive diagnostic accuracy. METHODS: Data in 19,410 cardiopulmonary bypass procedures were randomly divided into training (n = 9705) and validation (n = 9705) datasets. Multivariate logistic regression was used to determine the best predictive models for AKI (RIFLE [renal Risk, Injury, Failure, Loss of renal function and End-stage renal disease] classification), incremental predictive value of minimum cardiopulmonary bypass DO2i, and optimal threshold. RESULTS: Minimum DO2i was significantly associated with any AKI, AKI risk, and AKI injury or greater class in both datasets (validation dataset; any AKI odds ratio [OR], 0.993; 95% confidence interval [CI], 0.991-0.995; P < .001; AKI risk OR, 0.994; 95% CI, 0.992-0.996; P < .001, AKI injury or greater 0.993; 95% CI, 0.991-0.996; P < .001), representing on average a 7% increase in the likelihood of AKI for every 10-mL/min/m2 decrease in DO2i. Diagnostic accuracy was similar for both datasets, with an optimal DO2i threshold of 270 mL/min/m2. The odds of any AKI were increased by 52% in those below the threshold (OR, 1.52; 95% CI, 1.29-1.77; P < .001). CONCLUSIONS: This study confirms previous findings that minimum DO2i during cardiopulmonary bypass is independently associated with AKI, supporting previous findings in a broader-risk, multicenter cohort.
Authors: Mark Broadwin; Monica Palmeri; Tyler Kelting; Robert Groom; Michael Robich; F Lee Lucas; Robert Kramer Journal: J Extra Corpor Technol Date: 2022-06
Authors: Emily Foreman; Morgan Eddy; Jenny Holdcombe; Phoebe Warren; Lisa Gebicke; Pamela Raney; Wilson Clements; James Zellner Journal: J Extra Corpor Technol Date: 2021-12
Authors: Elena Carrasco-Serrano; Pablo Jorge-Monjas; María Fé Muñoz-Moreno; Esther Gómez-Sánchez; Juan Manuel Priede-Vimbela; Miguel Bardají-Carrillo; Héctor Cubero-Gallego; Eduardo Tamayo; Christian Ortega-Loubon Journal: J Clin Med Date: 2022-05-28 Impact factor: 4.964